Table 1.
Metabolites | Targets | Biological effects (References) |
---|---|---|
SCFAs | Human | Bind-specific G protein-coupled receptor29,30
Activate T cells29,30 Reduce NF-κB protein expression29,30 |
Mice | Increase calcium absorption
31
Stimulate intestinal serotonin synthesis31,32 Inhibition of osteoclast differentiation and bone resorption 31 |
|
Amino acid metabolites | Human | Serotonin production
36
Activate the TRPV1 receptor 37 |
Mice | Activate G protein-coupled receptor 3535
Impaired tryptophan canine metabolic pathway35,40 |
|
LPS | Human | Reduce pain threshold
42
Increase inflammatory factor IL-1β, TNF-α, and IL-6 levels 42 Increase the expression of DRG neurons, TRPA1, and TRPV1 proteins 42 |
Rat | Increase postoperative pain and delay wound growth
41
Increase inflammatory factor IL-1β, COX-2, and PGE2 levels 44 |
|
Succinic acid | Yolk | Inhibit the activity of PLA247 |
Rat | Bind to GRP91 receptor and promote IL-1β and NO release 49 |
DRG, dorsal root ganglion; LPS, Lipopolysaccharide; NF-κB, nuclear factor kappa-B; SCFA, short-chain fatty acid